Japanese Journal of Lung Cancer最新文献_第4页

Medical Economics in Lung Cancer 肺癌的医学经济学

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.275

Y. Goto

引用次数: 0

Investigation of the Current Surgical Practice in Patients with Thymic Epithelial Tumors Among Board-certified Surgeons of the Japanese Association for Chest Surgery: Does a Discrepancy Exist Between Clinical Practice Guidelines and Clinical Practice? 日本胸科学会委员会认证外科医生中胸腺上皮肿瘤患者的当前手术实践调查：临床实践指南和临床实践之间是否存在差异？

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.280

K. Fukumoto, S. Mori, H. Yoshioka, T. Okasaka, T. Taniguchi, Kikuo Shigemitsu, K. Narita, T. Fukui, Shota Nakamura, Toyofumi Fengshi Chen-Yoshikawa

引用次数: 0

A Case of Radiation Recall Pneumonitis Caused by Nivolumab+Ipilimumab Combination Therapy 尼沃单抗+依匹单抗联合治疗放射性回忆性肺炎1例

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.319

Yume Ikeda, H. Yoshioka, Yuta Okazaki, Kentaro Nakanishi, Kiyori Goto, T. Ikoma, Mari Fukai, Y. Takeyasu, Y. Yamanaka, Satoaki Nakamura, T. Kurata

引用次数: 0

Pulmonary Pleomorphic Carcinoma: Its Clinical Behavior, Prognostic Factor, and Keys to Treatment 肺多形性癌的临床表现、预后因素及治疗要点

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.292

Yoshinori Handa, Takuhiro Ikeda, Hideaki Hanaki, Yoshihiro Miyata, Kenichi Yoshimura, Morihito Okada, Hidenori Mukaida

{"title":"Pulmonary Pleomorphic Carcinoma: Its Clinical Behavior, Prognostic Factor, and Keys to Treatment","authors":"Yoshinori Handa, Takuhiro Ikeda, Hideaki Hanaki, Yoshihiro Miyata, Kenichi Yoshimura, Morihito Okada, Hidenori Mukaida","doi":"10.2482/haigan.63.292","DOIUrl":"https://doi.org/10.2482/haigan.63.292","url":null,"abstract":"Objective. Due to its rarity, the clinical behaviour of pulmonary pleomorphic carcinoma has not been elucidated. This study aimed to investigate the prognosis and prognostic factors of pulmonary pleomorphic carcinoma, especially factors associated with early recurrence and death. Methods. We retrospectively investigated 44 cases of pulmonary pleomorphic carcinoma. All patients underwent complete surgical resection. Factors affecting survival were assessed by the Kaplan-Meier method, and Cox regression and logistic regression analyses. Results. The prognosis of pleomorphic carcinoma was severe. In particular, there were high rates of early recurrence and death after surgery (the 1-year overall survival and recurrence-free survival rates were 52.6% and 45.8%). Although pleural invasion (P=0.95) and lymphatic invasion (P=0.39) did not affect the prognosis, patients with vascular invasion had a significantly worse prognosis than patients without vascular invasion (P=0.042). Similarly, tumors consisting mainly of sarcomatous elements showed a poorer prognosis than those consisting mainly of epithelial components (P=0.094). A multivariable Cox regression analysis revealed that vascular invasion was independently associated with a poor prognosis (hazard ratio, 3.11; 95% confidence interval, 1.04-13.3; P=0.026), and tumors consisting mainly of sarcomatous elements tended to have a poor prognosis (hazard ratio, 2.21; 95% confidence interval, 0.88-6.29; P=0.089). In addition, vascular invasion and tumors consisting mainly of sarcomatous elements were identified as risk factors for early recurrence and death after surgery by a multivariable logistic regression analysis. Conclusions. The prognosis of patients with pulmonary pleomorphic carcinoma is severe. Vascular invasion and tumors consisting mainly of sarcomatous elements are poor prognostic factors.","PeriodicalId":35081,"journal":{"name":"Japanese Journal of Lung Cancer","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135937193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Case of Occult Prostate Cancer with Low Serum Prostate-specific Antigen That Was Diagnosed by Lung Biopsy 肺活检诊断低血清前列腺特异性抗原隐匿性前列腺癌1例

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.308

Yuji Nomata, Kunihiko Hashimoto, K. Narita, Y. Arai, Matsuyoshi Maeda

引用次数: 0

左側IIIA期非小細胞肺癌に対する化学放射線療法逐次durvalumab後の切除で病理学的完全奏効を確認し得た右側IIA期非小細胞肺癌の1例左侧IIA期非小细胞肺癌的化学放射线疗法依次durvalumab后切除，确认病理学完全奏效的右侧IIA期非小细胞肺癌1例

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.302

Kaoru Yoshida, Koji Inoue, T. Katsuta, S. Tachibana, Haruka Kondo, Junya Nakamura, Shohei Nozu, Kento Aibara, N. Nakanishi, T. Moritaka

引用次数: 0

第195回関東支部学術集会第195回关东支部学术集会

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.325

引用次数: 0

乳頭腺腫の悪性転化と考えられた乳頭型肺腺癌の1例被认为是乳头状腺瘤恶性转化的乳头状肺腺癌的一个例子

Japanese Journal of Lung Cancer Pub Date : 2023-08-20 DOI: 10.2482/haigan.63.314

Shugo Takahashi, Yoshitaro Saito, Masayo Murakami, A. Goto, I. Matsuzaki

引用次数: 0

第63回九州支部学術集会第63回九州支部学术集会

Japanese Journal of Lung Cancer Pub Date : 2023-06-20 DOI: 10.2482/haigan.63.224

引用次数: 0

第117回関西支部学術集会第117回关西支部学术集会

Japanese Journal of Lung Cancer Pub Date : 2023-06-20 DOI: 10.2482/haigan.63.252

引用次数: 0